BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 9477669)

  • 1. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
    Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
    Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
    Rex JH; Bennett JE; Sugar AM; Pappas PG; van der Horst CM; Edwards JE; Washburn RG; Scheld WM; Karchmer AW; Dine AP
    N Engl J Med; 1994 Nov; 331(20):1325-30. PubMed ID: 7935701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
    Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
    Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J;
    Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
    Colombo AL
    Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of treatment of candidemia in children whose central catheters were removed or retained.
    Eppes SC; Troutman JL; Gutman LT
    Pediatr Infect Dis J; 1989 Feb; 8(2):99-104. PubMed ID: 2704608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
    Pappas PG; Rex JH; Lee J; Hamill RJ; Larsen RA; Powderly W; Kauffman CA; Hyslop N; Mangino JE; Chapman S; Horowitz HW; Edwards JE; Dismukes WE;
    Clin Infect Dis; 2003 Sep; 37(5):634-43. PubMed ID: 12942393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
    Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidemia in children.
    Zaoutis T
    Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.